Last update 08 May 2025

PDGFRβ x JAK x ROCK

Basic Info

Related Targets
PDGFRβJAKROCK

Related

1
Drugs associated with PDGFRβ x JAK x ROCK
AR-13154
Target
JAK x PDGFRβ x ROCK
Mechanism
JAK inhibitors [+2]
Active Org.
Aerie Pharmaceuticals, Inc.Aerie Pharmaceuticals, Inc.
Originator Org.
Aerie Pharmaceuticals, Inc.Aerie Pharmaceuticals, Inc.
Active Indication
Dystrophy, Macular
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with PDGFRβ x JAK x ROCK
Login to view more data
100 Translational Medicine associated with PDGFRβ x JAK x ROCK
Login to view more data
0 Patents (Medical) associated with PDGFRβ x JAK x ROCK
Login to view more data
1
Literatures (Medical) associated with PDGFRβ x JAK x ROCK
Investigative Ophthalmology & Visual Science
Effectiveness of AR-13154 monotherapy and combination therapy in animal models of wet age-related macular degeneration and proliferative diabetic retinopathy

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free